Table: Garna Biosciences -Q1 group results

Carna Biosciences

11/05/2018 07:30

May 11 (Reuters)- 
             Garna Biosciences Inc 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended        Year to  
                Mar 31, 2018        Mar 31, 2017      Dec 31, 2018  
                   LATEST             YEAR-AGO           LATEST     
                   RESULTS             RESULTS          FORECAST    
  Sales            211 mln             196 mln            1.19      
                 (+7.7 pct)          (-13.0 pct)       (+81.1 pct)  
  Operating     loss 188 mln        loss 113 mln      loss 679 mln  
  Recurring     loss 191 mln        loss 113 mln      loss 694 mln  
  Net           loss 194 mln        loss 118 mln      loss 758 mln  
  EPS          loss 20.36 yen      loss 12.80 yen    loss 79.39 yen 
  Ann Div                                NIL               NIL      
  -Q2 div                                NIL               NIL      
  -Q4 div                                NIL               NIL      
  
  NOTE - Garna Biosciences Inc. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4572.T